13 results on '"Sampath, Gadey"'
Search Results
2. The impact of COVID-19 pandemic on rabies post-exposure prophylaxis services in Asia
3. Rabies awareness in eight Asian countries
4. Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman-Moore strain) manufactured in India
5. A comparative study on the immunogenicity, safety and tolerance of purified duck embryo vaccine (PDEV) manufactured in India (Vaxirab) and Switzerland (Lyssavac-N): A randomized simulated post-exposure study in healthy volunteers
6. Immunogenicity, safety and tolerance of a purified duck embryo vaccine (PDEV, VAXIRAB) for rabies post-exposure prophylaxis: Results of a multicentric study in India
7. Introduction of intradermal rabies vaccination – A paradigm shift in improving post-exposure prophylaxis in Asia
8. The real cost of rabies post-exposure treatments
9. Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study
10. Immunogenicity and safety study of Indirab: A Vero cell based chromatographically purified human rabies vaccine
11. Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman-Moore strain) manufactured in India.
12. A comparative study on the safety and immunogenicity of purified duck embryo cell vaccine (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab)
13. Corrigendum to “A comparative study on the safety and immunogenecity of purified duck embryo cell vaccine (PDEV, VAXIRAB) with purified chick embryo cell vaccine (PCEC, RABIPUR) and purified vero cell rabies vaccine (PVRV, VERORAB)” Vaccine 28 (2010) 148–151
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.